Growth marketing for longevity brands
Acquisition for longevity and anti-aging brands - a young, high-ticket category where recurring membership economics, not cold paid ROAS, are the only thing that makes CAC survivable.
Market context
The core longevity services market sits at ~$27.6B in 2025 and is projected to reach ~$67B by 2035 (9.4% CAGR), nested inside a ~$1.8T global wellness market. The 2026 urgency is a validated DTC membership model plus a flood of capital - Function Health closed a $298M Series B in Nov 2025 at a $2.5B valuation (200K+ members at $365/yr), Superpower raised $30M at $300M+, and Bryan Johnson’s Blueprint raised $60M - signaling life-extension has crossed from billionaire experiment into scalable, mainstream consumer demand.
The longevity growth playbook
A high price and a long consideration cycle make cold paid brutal - Forward Health raised $650M and shut down in 2024 when consumer CAC outran LTV.
Match channel to consideration level, not just CPMs
Meta (Instagram/Reels) is the volume workhorse for affluent 40–60 buyers - Health & Wellness posts the highest Meta conversion rate of any category at 2.70% - but CPMs rose ~20% in 2025, so it can’t stand alone. Layer YouTube and long-form podcasts for the education-heavy, high-consideration purchase (a $4K–$40K decision gets researched, not impulse-bought), and reserve Google Search for bottom-funnel intent.
Lead with "biological age" and truth-from-bloodwork hooks
The winning angle reframes aging as measurable and fixable: "your bloodwork tells the truth," "know your biological age," "optimize, don’t just treat." Pair it with founder/physician authority on camera - the Function/Fountain Life/Bryan Johnson playbook proves a credible face plus a specific biomarker promise out-converts generic "feel younger" messaging.
Use a diagnostic tripwire into a membership
The dominant structure is a blood panel or biomarker test as a low-friction tripwire ($199–$500; $365/yr at Function), which converts into a recurring membership plus high-AOV concierge upsells ($2K–$5K/yr tiers). The panel monetizes acquisition and creates the personalized "here’s what’s wrong" hook that sells the ongoing relationship.
Engineer LTV through retesting cadence + recurring Rx
Retention is the entire game. Stack the levers: annual membership renewal, quarterly/biannual retesting (a natural re-engagement trigger), and recurring peptide/TRT/NAD+/supplement fulfillment. Bi-monthly and quarterly replenishment retains better than monthly, and the telehealth-supplement hybrid benchmark (Hims) runs ~85% retention on 2.2M+ subscribers.
Compliance landmines
Common mistakes in longevity
- Making implied disease-treatment claims ("reverse aging," "prevent Alzheimer’s") on supplements/peptides - DSHEA only permits structure/function claims with the FDA disclaimer.
- Selling the blood panel as a one-off transaction instead of a tripwire into a subscription - you eat CAC once and never earn the LTV.
- Weak scientific credibility: no named physician, no cited biomarkers - affluent 40–60 buyers won’t convert on vibes.
- Treating GLP-1/peptides as a standalone commodity in a price war instead of bundling into a membership with diagnostics.
- Optimizing to first-purchase ROAS on Meta and killing winning campaigns - 1.5–3× first-order ROAS is fine if blended LTV lands.
What good looks like
- LTV:CAC 3:1 or better; rework if CAC exceeds ~40% of LTV
- Blended ROAS 3–6× on repeat/membership; 1.5–3× acceptable on new acquisition
- Cost-per-lead $15–$50; supplement/DTC CPA $30–$70
- Monthly churn under 5–8% (top-quartile under 3%); annual renewal 80%+
Segments we work in
What we do for longevity brands
Longevity marketing FAQ
Ready to lower CAC on your longevity brand?
A 30-minute call with a senior strategist. Free account audit included. No pitch deck - a written plan you can keep, whether you work with us or not.
Book a free strategy call